AI's Impact on Medicare Claims Review: Balancing Innovation and Oversight
The integration of artificial intelligence (AI) into health care claims review is attracting significant attention from regulatory bodies, specifically under federal health programs. The Electronic Frontier Foundation (EFF) has initiated litigation against the Centers for Medicare and Medicaid Services (CMS), alleging a lack of response to a Freedom of Information Act (FOIA) request. This request pertains to the Medicare Wasteful and Inappropriate Service Reduction (WISeR) model, an AI-driven prior authorization pilot aimed at optimizing Medicare service payments.
Launched in June 2025, the WISeR model operates in states including Arizona, New Jersey, and Texas. It blends AI tools with human review to enhance care quality, reduce unnecessary spending, and minimize fraud within Traditional Medicare. This implementation marks a shift in CMS practices by providing detailed advance reviews for services deemed high-risk for fraud and misuse.
A crucial component of WISeR is the fusion of AI capabilities with human oversight in claims review. CMS assures that payment decisions are made by licensed clinicians following standardized procedures, complying with the 2024 Final Rule, which prohibits sole reliance on AI for denial decisions in Medicare programs.
Industry data reveals that the adaptation of private sector norms has prompted this move. A significant number of Medicare Advantage beneficiaries undergo prior authorization, with AI commonly utilized for utilization management and fraud detection. WISeR's objective is to streamline reviews and reduce unwarranted claims while ensuring access to necessary care.
However, the EFF argues that WISeR's introduction may relate to increasing care denial rates in participating states, suggesting financial incentives could affect denials. Their lawsuit seeks transparency in the program’s functions and impacts, highlighting concerns about potential biases and inappropriate care decisions.
Broad regulatory trends are increasingly scrutinizing AI's role in health care claims adjudication. New state laws, such as those in Arizona and Nevada, require human involvement in coverage decisions, challenging AI's sole reliance. Similar legislative efforts in states like California reinforce the need for clinician-led assessments.
As the industry navigates new regulations, discussions on AI's role in claims processing are critical. Balancing AI efficiency with essential human oversight remains a significant concern for regulators and health care providers. While the EFF lawsuit focuses on a federal program, its broader implications for commercial payers and stakeholders across states are under close watch. Future legal and regulatory developments will necessitate vigilance among industry participants to ensure compliance and effective risk management practices.